Desjardins Global Asset Management Inc. Bio Rad Laboratories, Inc. Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 77 shares of BIO stock, worth $24,663. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77
Previous 75
2.67%
Holding current value
$24,663
Previous $26,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.3MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$611 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$497 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$418 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$348 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$228 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.89B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...